# A Randomized Controlled Trial of TNK-tPA Versus Standard of Care for Minor Ischemic Stroke With Proven Occlusion

Study · id `cardio:ct-nct02398656` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02398656](<https://clinicaltrials.gov/study/NCT02398656>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02398656

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1274 participants.

## Technical summary

Registry record NCT02398656. Randomized; single masking; primary purpose treatment. Start 2015-04-01 (actual); primary completion 2024-01-19 (actual). Results posted on 2025-01-31.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 1274 participants (enrolled count; ClinicalTrials.gov record NCT02398656, source copy `cardio:ctgov-nct02398656-2025-01-31`, retrieved 2026-10-26)
- Started: 2015-04-01 (actual) (ClinicalTrials.gov record NCT02398656, source copy `cardio:ctgov-nct02398656-2025-01-31`, retrieved 2026-10-26)
- Primary completion: 2024-01-19 (actual) (ClinicalTrials.gov record NCT02398656, source copy `cardio:ctgov-nct02398656-2025-01-31`, retrieved 2026-10-26)
- Completion: 2024-04-10 (actual) (ClinicalTrials.gov record NCT02398656, source copy `cardio:ctgov-nct02398656-2025-01-31`, retrieved 2026-10-26)
- Results first posted: 2025-01-31 (ClinicalTrials.gov record NCT02398656, source copy `cardio:ctgov-nct02398656-2025-01-31`, retrieved 2026-10-26)
- Countries: Australia; Austria; Brazil; Canada; Finland; Ireland; New Zealand; Singapore; Spain; United Kingdom (ClinicalTrials.gov record NCT02398656, source copy `cardio:ctgov-nct02398656-2025-01-31`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02398656-2025-01-31`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Randomized Controlled Trial of TNK-tPA Versus Standard of Care for Minor Ischemic Stroke With Proven Occlusion
- Acronym: TEMPO-2
- Condition: Stroke, Acute
- Intervention (Drug): Tenecteplase
- Intervention (Drug): Antiplatelet treatment
- Lead sponsor: University of Calgary
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry intervention name matches this record: Tenecteplase (`cardio:tenecteplase`)
- Registry lists this organization as the lead sponsor: University of Calgary (`cardio:org-university-of-calgary`)

### Main results

- Registry lists this paper as a reference of type result; PubMed types it as a trial report that names this trial and no other, dated on or after the trial start, and its title marks no secondary, follow-up or other further analysis: Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial (`cardio:pubmed-38768626`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Thrombolysis With Tenecteplase for Minor Disabling Stroke: Secondary Analysis of the TEMPO-2 Randomized Clinical Trial (`cardio:pubmed-41143808`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Outcomes After Minor Ischemic Stroke in Older Patients Treated With IV Thrombolysis vs Standard of Care in the TEMPO-2 Trial (`cardio:pubmed-41980227`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Tenecteplase versus standard care for minor ischaemic stroke according to the baseline occlusion status in TEMPO-2 trial (`cardio:pubmed-42734928`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: dc85fd4e47516b6b1fac1c8cff412f71b829dd703cf8044bbc0af232d582a436
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
